Chiltern was founded in 1982 and is headquartered in Berkshire, UK. Chiltern has grown to have more than 2,200+ personnel working at 30+ sites in 40 countries and an field resources located in an additional 14 countries. Chiltern specializes in the planning, management, and execution of clinical trials from early phase studies through Phase IIb-IV and post approval. The company has expertise in neurology, cardiovascular, oncology, respiratory, endocrinology, infectious diseases, ophthamology and dermatology. Chiltern has a stated goal of becoming the premier mid-tier specialized CRO. Their purchase of Ockham, a niche oncology CRO, in July 2014.
Chiltern is positioned to support clinical trials across the globe with the company claiming more than 8000 investigators listed in its database. Our panel viewed Chiltern as.................................
<Thumbnail and link to interactive dashboard to research more...>